SARS-CoV-2 and amyloid beta peptide: an unhealthy duo
- Victoria Belen Ayala-Peña
Abstract
The volume of knowledge that the scientific community has compiled about
SARS-CoV-2 and amyloid beta peptide is scarce, but it is growing every
day. The interaction between the virus and the amyloid beta peptide is
poorly understood and some data are unclear. The long-term consequences
of SARS-CoV-2 infection on human health remain uncertain at this time.
The present work provides a discussion about the association between the
amyloid beta peptide and COVID-19.